FIELD: medicine.
SUBSTANCE: method involves determining alpha-1 proteinase inhibitor available in patient blood at exacerbation stage. The value is compared to normal reference value. Alpha-1 proteinase inhibitor level growing 1.8-2.3 times as high when compared to the reference value, high pemphigus activity is considered to be the case. The value growing 1.4-1.7 times as high, low pemphigus activity is considered to be the case.
EFFECT: high reliability of prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING PEMPHIGUS CLINICAL COURSE SEVERITY DEGREE | 2006 |
|
RU2316006C1 |
| METHOD FOR ESTIMATING PEMPHIGUS TREATMENT EFFECTIVENESS | 2006 |
|
RU2316005C1 |
| METHOD FOR ESTIMATING PSORIATIC ERYTHRODERMIA TREATMENT EFFECTIVENESS | 2005 |
|
RU2297004C1 |
| METHOD FOR PREDICTING THE CHANCE FOR OSTEOMYELITIS CHRONIZATION IN CHILDREN | 2006 |
|
RU2304784C1 |
| METHOD FOR EVALUATING INFLAMMATORY PROCESS ACTIVITY AT PSORIASIS | 2005 |
|
RU2290645C1 |
| METHOD OF ASSESSING INFLAMMATORY PROCESS ACTIVITY IN SARCOIDOSIS | 2010 |
|
RU2423701C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD OF PROBABILITY PREDICTION OF CHILDREN CHRONIC HAEMATOGENOUS OSTEOMYELITIS DEVELOPMENT | 2007 |
|
RU2341798C1 |
| METHOD FOR DETERMINING BLOOD STATE OF AGGREGATION IN INFANTINE INFLAMMATORY PROCESS CASES | 2006 |
|
RU2319965C1 |
| METHOD OF TREATING INFLAMMATORY EXUDATIVE POSTOPERATIVE REACTIONS FOLLOWING IMPLANTATION OF INTRAOCULAR LENS | 2008 |
|
RU2381775C1 |
